Impaired adipogenesis induced by the PPARγ inhibitors GW9662 and BADGE results in an increased bacterial infection in the skin and colon (Dokoshi et al., 2018; Zhang et al., 2015). This evidence concerns the gene PPARG and bacterial infectious disease.